Wikidata

(Q79857933)

English

Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck

scientific article published on 01 April 2007

In more languages

Statements

title
Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17332932
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17332932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q79857933&oldid=1754189327"